Safer Soap Act.

Assembly Member Lee's proposal to prohibit specific antimicrobial chemicals in consumer soaps would establish new regulations for manufacturers while maintaining access to these ingredients for healthcare facilities. Starting January 1, 2028, the manufacture and sale of hand soaps and body washes containing benzalkonium chloride, benzethonium chloride, or chloroxylenol would be prohibited in California.

The legislation creates a registration system requiring manufacturers to document their compliance by July 1, 2028. Companies must provide product descriptions, pay registration fees, and submit compliance statements to the Department of Toxic Substances Control (DTSC). The department would maintain authority to request technical documentation, including analytical test results, to verify adherence to the prohibitions.

The enforcement framework includes minimum penalties of $10,000 per violation, with proceeds directed to a new Safer Soap Act Fund. The Attorney General may pursue injunctive relief against violators, while the DTSC would issue violation notices and assess penalties based on factors such as violation severity and compliance efforts. Implementation depends on sufficient funding through the Toxic Substances Control Account and legislative appropriations.